Which Patients Should Receive Dual Defibrillators? Results of DATAS
The dual-chamber (DC) implantable cardioverter defibrillator (ICD) was primarily introduced in the market to add atrial-based pacing for those patients simultaneously affecting by bradycardia and fatal ventricular arrhythmias. Following the successful introduction of the original VVED ICDs, device capabilities were rapidly expanded by the addition of AV discrimination and atrial anti-tachycardia therapies (DDED ICDs). It was suggested that these sophisticated devices would overcome the limitations of the single chamber (SC) devices and that their recommended use would be extended.
KeywordsVentricular Pace Atrial Pace Implantable Defibrillator Dual Chamber Atrial Tachyarrhythmia
Unable to display preview. Download preview PDF.
- 13.Dries DL, Exner DV, Gersh BJ et al (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 32:695–703PubMedCrossRefGoogle Scholar
- 22.Deisenhofer I, Kolb Ch, Ndrepepa G et al (2001) Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 12:134–142PubMedCrossRefGoogle Scholar
- 23.Wilkoff B, Gillberg J, De Souza C (2001) The enhanced PR logic dua chamger tachyarrhythmia detection algorithm: retrospective analysis of supraventricular tachycardia with long PR intervals. J Am Coll Cardiol 37(Suppl 2):131A (abs)Google Scholar
- 28.Gregoratos G, Cheitlin MD, Conill A et al (1998) ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary — a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 97:1325–1335PubMedGoogle Scholar